Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
50 Cards in this Set
- Front
- Back
Compliance
|
implementation of a prescriber's care or course of treatment by the patient. also called "adherence". Opposite called "noncompliance/nonadherence"
|
|
Medication Error
|
any preventable adverse drug event involving inappropriate medication use that may or may not cause patient harm.
|
|
Additive effects
|
the effect of the combination of 2+ drugs with similar actions is equivalent to the sum. Ex: 1 + 1 = 2
|
|
Adverse drug event
|
any undesirable occurrence related to administering/failing to administer a prescribed med
|
|
Adverse drug reaction
|
Unexpected/unintended/undesired or excessive response to a med given at therapeutic doses.
|
|
Agonist
|
a drug that binds to and stimulates the activity of one or more receptors in the body.
|
|
Allergic reaction
|
an immunologic hypersensitivity reaction
|
|
Antagonist
|
a drug that binds to and inhibits the activity of one ore more receptors in the body. Also called "inhibitors" or "blockers"
|
|
Antagonist effects
|
drug interactions in which the sum/combination of 2+ drugs is less than the individual effect of the drugs given alone. Ex: 1 + 1 = less than 2. generally causes a "blocking" effect
|
|
Bioavailability
|
percentage of drug absorption for a given drug and route
|
|
Biotransformation
|
One or more bio chemical reactions involving a parent drug; occurs mainly in the liver and produces a metabolite that is active or inactive.
|
|
Blood-Brain barrier
|
barrier syst that restricts passage of various chems and microscopic entities between blood and CNS but still allows for passage of oxygen.
|
|
Contraindication
|
any condition, especially one related to a disease state or patient characteristic, including current or recent drug therapy that renders particular therapy unsuitable
|
|
Cytochrome P-450
|
general name for a large class of enzymes that play a significant role in drug metabolism.
|
|
Dissolution
|
Process by which solid forms of drugs disintegrate in the GI tract and become soluble before being absorbed into circulation.
|
|
Drug effects
|
the physiologic reactions of the body to a drug
|
|
Drug-Induced Teratogenesis
|
development of congenital anomalies or defects in the developing fetus caused by the toxic effects of drugs
|
|
Drug interaction
|
interaction between 2+ drugs in the body - related to enzymes requires for metabolism
|
|
First-pass effect
|
initial metabolism in the liver of a drug absorbed from the GI tract before the drug reaches systemic circ
|
|
Idiosyncratic reaction
|
an abnormal and unexpected response to a med, other than an allergic reaction, that is peculiar to an individual patient
|
|
Incompatibility
|
when a drug interaction results in chemical deterioration of 1+ of given drugs
|
|
Intraarticular
Intrathecal |
within a joint
within a sheath |
|
Medication error
|
any preventable adverse drug event involving inappropriate use of drug by patient or medical work. it may or may not cause patient harm.
|
|
Peak effect
Peak levels |
time req for drug to reach maximum therapeutic response
max concentration of drug in body after admin |
|
Pharmaceutics
|
the science of preparing and dispensing drugs, including dosage form design
|
|
Pharmacodynamics
|
study of biochemical and physiologic interactions of drugs at their sites of activity.
|
|
Pharmacogenetics
|
study of influence of genetic factors in drug response
|
|
Pharmacokinetics
|
rate of drug distribution among various body compartments after a drug has entered the body
|
|
Prodrug
|
inactive drug dosage form that is converted to an active metabolite by various bicochem reactions once it is inside the body
|
|
Therapeutic drug monitoring
|
process of measuring drug peak and trough levels to gauge level of patients drug exposure and allow adjustments of dosages with goals of maxmizing effects and minimizing toxicity
|
|
Synergistic effects
|
drug interactions where the effect of a combination of 2+ drugs with similar actions is greater than sum of individual effects of same drug given alone. Ex: 1 + 1 = greater than 2
|
|
Therapeutic index
|
the ratio between the toxic and therapeutic concentrations of a drug
|
|
Black box warning
|
type of warning that appears in a drug's prescribing information, required by the FDA alerting prescribers of serious adverse events
|
|
Investigational New Drug (IND)
|
a drug not yet approved by the FDA for market but for experiments to determine safety/efficacy.
|
|
narcotic
|
drugs used in clinical settings to refer to any medically administered controlled substance and in legal settings to refer to any illicit drug.
|
|
Orphan drugs
|
special category of drugs used to treat those with rare diseases
|
|
Medication Reconciliation
|
procedure implemented by health care providers to maintain an accurate and up-to-date list of medications for all patients b/t all phases of health care delivery
|
|
Cognitive domain
|
domain involved in the learning and storage of basic knowledge. the thinking portion of the learning process
|
|
Psychomotor domain
|
domain involved in the learning of a new procedure or skill
|
|
Iatrogenic effects
|
unintentional adverse effects that are caused by the actions of a prescriber or other health care professional or by a specific treatment.
|
|
Phytochemicals
|
the pharmacologically active ingredients in herbal remedies
|
|
Adjuvant analgesic drugs
|
drugs that are added as a second drug for combined therapy with a primary drug and may have additive or independent analgesic properties
|
|
Agonist-Antagonists
|
substances that bind to a receptor and cause a partial response that is not as strong as that caused by an agonist (also known as a partial agonist)
|
|
Analgesic ceiling effect
|
occurs when a given pain drug no longer effectively controls a pt's pain despite the admin of the highest safest dosage
|
|
Analgesic
|
meds that relieve pain without causing a loss of consciousness (pain-killers)
|
|
Breakthrough pain
|
pain that occurs between doses of pain meds
|
|
Central pain
|
pain resulting from any disorder that causes CNS damage
|
|
Deep pain
|
pain that occurs in tissues below skin level; opposite of superficial pain
|
|
Gate Theory
|
most common and well-described theory of pain transmission and pain relief. it uses a gate model to explain how impulses from damaged tissues are sensed in the brain
|
|
Neuropathic pain
|
pain that results from disturbance of function or pathologic change in nerve
|